OmniActive releases new data to substantiate capsaicinoids and salacia extract ingredients
“[These studies] accompany the rapidly expanding base of research on OmniActive’s innovative, science-backed ingredients,” the company said in a press release.
The presentations will be made by Vijaya Juturu, senior manager of global scientific and clinical affairs at OmniActive Health Technologies.
Capsaicinoid fo weight management
In its study titled “Capsaicinoids Decrease Appetite Measures – An Open Label Study in Free Living Individuals,” OmniActive researchers found that there were “no statistically significant increase in heart rate or blood pressure with one-week supplementation” of the company’s Capsimax, an ingredient containing the capsaicinoid of red peppers.
"The data showed that Capsimax Capsicum Extract may be beneficial for decreasing measures of appetite, which can support weight management," Lynda Doyle, VP of Global Market, OmniActive Health Technologies, said in a press release. "We are excited to further expand our growing research surrounding Capsimax."
The researchers added that future studies should examine the long-term effects of Capsimax supplementation on appetite, weight management, and body composition using a randomized, double-blind, placebo-controlled trial.
Salacia for sugar levels
Another weight management ingredient OmniActive will present on is the new OmniLean, made out of Salacia extract and launched earlier this month at Engredea. According to the company, the free-flowing powder can be used for a variety of applications including tablets, capsules and powders – e.g. meal replacements, protein, etc.
The study is titled “Salacia Extract Improves Post-Prandial Glucose and Insulin Response: A Randomized Double-Blind, Placebo-Controlled, Crossover Study in Healthy Volunteers."
"Our purpose was to evaluate the acute effect of Salacia extract, an alpha-glucosidase inhibitor, on glucose and insulin response (to an oral sucrose load) in healthy individuals," Dr. Jayant Deshpande, CTO of OmniActive Health Technologies, said in a press release.
"Through its ability to inhibit alpha-glucosidase enzyme, [Salacia extract] shows tremendous potential to support healthy blood glucose and insulin levels by decreasing carbohydrate absorption," he added.
OmniLean is marketed as an ingredient to achieve multiple objectives, including healthy carbohydrate metabolism, fat metabolism, heart health, and weight management in one low dose ingredient.
The company guarantees the ingredient’s traceability through its PlantActive verification process, which standardizes both bioactives and bioactivity to ensure consistent performance of OmniLean.
